Clinical trial

68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment

NCT02673151

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-05-20

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2017-05-20Date precision: day

Registry last updated2022-01-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Adenocarcinomaunresolved

PSA Failureunresolved

Recurrent Prostate Carcinomaunresolved

Interventions

Computed Tomography (CT) scanPROCEDURE

68Ga-PSMA-11DRUG

Positron Emission Tomography (PET)PROCEDURE

Sponsors & collaborators

Andrei Iagarulead sponsor

Mapped research locations

Palo AltoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02673151 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.